Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Insiders Show Strong Belief in Charles Colvard Ltd

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
TMUS stock news
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

Insiders within Charles & Colvard, Ltd. have recently been increasing their holdings, showing strong belief in the company’s potential. Director Ollin B Sykes bought 44,940 shares at an average price of $0.38, totaling approximately $17,287. President and CEO Don O’Connell also acquired 30,000 shares at an average price of $0.34, costing around $10,164. These insider trades indicate optimism for the future of Charles & Colvard, even after the company reported a quarterly loss of 9 cents per share on February 13th.

CTHR Stock Price Jumps 3.38% on March 4, 2024: Is This the Start of a Trend?

On March 4, 2024, CTHR stock experienced a positive price momentum, with shares increasing by $0.01 since the previous market close. This represents a 3.38% rise in the stock price, opening at $0.36, which was $0.01 higher than its previous close.

Investors should take note of the price movement on March 4 and consider whether this short-term increase is indicative of a larger trend or simply a temporary fluctuation. It is important to conduct thorough research and analysis before making any investment decisions regarding CTHR or any other stock.

CTHR Stock Performance Under Scrutiny: Revenue Decline and Net Loss Reported

On March 4, 2024, the stock performance of CTHR, or Charles & Colvard, was under scrutiny as the company released its financial data for the past year and the most recent quarter. According to CNN Money, CTHR reported a total revenue of $29.95 million for the past year, which was a decrease of 30.5% compared to the previous year. The total revenue for the most recent quarter was $7.91 million, showing a significant increase of 59.61% since the last quarter.

In terms of net income, CTHR reported a net loss of $19.58 million for the past year, which was a substantial decrease of 924.83% compared to the previous year. The net loss for the most recent quarter was $2.87 million, representing a decrease of 12.86% since the last quarter.

Earnings per share (EPS) for CTHR were also negatively impacted, with the company reporting an EPS of -$0.64 for the past year, a decrease of 950.4% compared to the previous year. The EPS for the most recent quarter was -$0.09, showing a decrease of 13.19% since the last quarter.

Overall, the financial data released by CTHR on March 4, 2024, painted a mixed picture of the company’s performance. Investors and analysts will be closely monitoring CTHR’s future financial reports to see if the company can turn around its negative performance and improve its bottom line.

Tags: CTHR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_ Charts for stock trading

Analyst Evaluations and Price Targets for Analog Devices NASDAQ ADI

Entertainment Trading online

Netflixs Triumph A ForwardThinking Approach to Streaming Success

Entertainment Markets and money

Disneys Strategic Initiatives for Success and Sustainability

Recommended

Finance_Cash

Important Information for Investors Dividend Distribution and Key Dates for First Commonwealth NYSE FCF Stock

2 years ago
iShares MSCI World ETF Stock

The Hidden Concentration Risk in Your Global ETF Portfolio

5 months ago
Assembly Biosciences Stock

Assembly Biosciences Shares Extend Losses Amid Heavy Selling Pressure

6 months ago

Raymond James Financial Services Advisors Inc. Decreases Holdings in Snap-on Incorporated: Examining Investment Strategy Shift and Analyst Perspectives

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon

Ocugen Shares Slide Despite Positive Clinical Trial Results

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

Realty Income’s Strategic Financing Defies High Interest Rate Environment

IBM Shares Face Pressure from Analyst Downgrades and Acquisition Concerns

Battalion Oil Navigates Debt and Operational Overhaul

Trending

Glencore Stock
Analysis

Glencore Shares Demonstrate Resilience Amid Copper Market Weakness

by Jackson Burston
March 25, 2026
0

While the broader copper market faces significant headwinds, shares in the diversified mining and trading giant Glencore...

Energiekontor Stock

Energiekontor Stock Gains Momentum from Policy Shifts

March 25, 2026
Bionxt Solutions Stock

BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents

March 25, 2026
Take-Two Stock

GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon

March 25, 2026
Ocugen Stock

Ocugen Shares Slide Despite Positive Clinical Trial Results

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Glencore Shares Demonstrate Resilience Amid Copper Market Weakness
  • Energiekontor Stock Gains Momentum from Policy Shifts
  • BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com